No Sanctions For GSK, But Both Sides Told To 'Dial It Back'

By Chris Villani (February 20, 2020, 3:05 PM EST) -- GlaxoSmithKline will not face sanctions for a call to the U.S. Food and Drug Administration tied to multidistrict litigation over whether its anti-nausea medication Zofran causes birth defects, a Boston federal judge ruled Thursday, but he admonished lawyers on both sides to "dial ... back" their rhetoric....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!